FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q4 2020

Top Holdings136 positions

Checking export access…
Activity:

IQVIA HOLDINGS INC

4M$724.5M4.4%$125.48+41.47%
9 qtrssince 2018-Q4
Increased
66

ALPHABET INC-CL C

361,094$632.6M3.8%$62.74+38.30%
9 qtrssince 2018-Q4
Decreased
0

T-MOBILE US INC

3.9M$532.5M3.2%$104.79+22.88%
3 qtrssince 2020-Q2
Increased
63

THERMO FISHER SCIENTIFIC INC

1.1M$519M3.1%$311.88+46.99%
5 qtrssince 2019-Q4
Increased
58
SPYSPY
PUT

SPDR S&P 500 ETF TRUST

1.4M$510.3M3.1%———
New
—

VISA INC-CLASS A SHARES

2.2M$487.4M2.9%$155.31+35.01%
9 qtrssince 2018-Q4
Increased
68

AON PLC-CLASS A

2.3M$479.9M2.9%$188.69+7.59%
3 qtrssince 2020-Q2
Increased
67

BOSTON SCIENTIFIC CORP

13.2M$475.9M2.9%$37.36-3.78%
2 qtrssince 2020-Q3
Increased
77

FIDELITY NATIONAL INFO SERV

3.1M$445.5M2.7%$102.06+22.35%
9 qtrssince 2018-Q4
Decreased
0

ARAMARK

11M$424.2M2.6%$26.050.00%
1 qtr
New
81

CENTENE CORP

6.9M$411.2M2.5%$57.70+2.12%
4 qtrssince 2020-Q1
Decreased
0

ANTHEM INC

1.3M$409.4M2.5%$246.70+18.95%
9 qtrssince 2018-Q4
Unchanged
0

MICROSOFT CORP

1.8M$391.1M2.4%$128.67+64.82%
9 qtrssince 2018-Q4
Increased
61

WABTEC CORP

5M$365.8M2.2%$62.64+13.18%
9 qtrssince 2018-Q4
Decreased
0
XLNXXLNXDelisted

XILINX INC

2.6M$362.4M2.2%——
1 qtr
New
80

CHARTER COMMUNICATIONS INC-A

546,931$361.8M2.2%$304.08+114.91%
9 qtrssince 2018-Q4
Decreased
0
ALXNALXNDelisted

ALEXION PHARMACEUTICALS INC

2.2M$351.1M2.1%——
1 qtr
New
80

NEW YORK TIMES CO-A

6.5M$338.9M2.0%$39.90+22.82%
3 qtrssince 2020-Q2
Decreased
0

ACCELERON PHARMA INC

2.6M$332.6M2.0%——
9 qtrssince 2018-Q4
Unchanged
0

RAYTHEON TECHNOLOGIES CORP

4.5M$324.8M2.0%$63.080.00%
1 qtr
New
71
$16.6B
AUM
136
Positions
Q4 2020
Filing
HI score · 1.0/5
Quarterly 13F Value Change
-15%Q3'19$12.2B+6%Q4'19$13B-16%Q1'20$10.9B+14%Q2'20$12.4B+13%Q3'20$14.1B+14%Q4'20$16.1B
Activity profile
$ moved · Q4'20
New38%Increased18%Decreased16%Exited28%
Composition
Equity vs derivatives
Equity97%Puts3%Calls0%
Holding period
Avg 3.4 quarters
<1Q28%1-4Q29%1-2Y16%2Y+26%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $16.6B across 136 positions as of Q4 2020. Top holdings: IQV (4.4%), GOOG (3.8%), TMUS (3.2%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.

Q4 2020 Summary

Active quarter - 42 new positions, 28 exits, 30 increased. Top move: ARMK (NEW, conviction 81). Portfolio: $16.6B across 136 positions.

Top holdings by portfolio weight

Total AUM$16B
IQV4.36%
GOOG3.80%
TMUS3.20%
TMO3.12%
V2.93%
AON2.89%
BSX2.86%
FIS2.68%
ARMK2.55%
CNC2.47%
Other2.46%

Portfolio allocation by GICS sector

Sectors10
Healthcare31.36%
Unknown20.34%
Communication Services14.18%
Financial Services10.86%
Technology9.25%
Industrials8.83%
Consumer Cyclical2.48%
Basic Materials1.86%
Utilities0.59%
Real Estate0.25%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown, Communication Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L48
Conviction44
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+9M shares+$755.7M
7Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q4 2024 → Q2 2026+7.8M shares+$277M
5Q
BSXBSXBoston Scientific Corp
Q2 2025 → Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used